The reduction of allogeneic blood transfusions in cardiac surgery using a blood saving program
Keywords:
hemodilution, thoracic surgery, blood transfusionAbstract
Antecedents and objectives: Cardiac surgery has been a process which traditionally requires large amounts of homologous blood transfusions. Due to the negative effects on perioperative morbimortality, and its cost, some alternatives have been developed in order to reduce or avoid giving a transfusion to the patients. The aim of this study is to put into practice and assess the effectiveness of a strategy for reducing the use of allogeneic transfusions in the cardiac surgery perioperative at the Ernesto Che Guevara Cardiology Hospital. Method: 151 patients, who were operated on with or without extracorporeal circulation, and who were inserted in a blood saving program that included acute intentional normovolemic hemodilution with autotransfusion during the year 2008, were studied in order to assess the effectiveness of such strategies. Results: It was possible to avoid the transfusions with allogeneic components in 55 percent of the patients (56.0 percent from the group intervened with extracorporeal circulation (ECC), and 52.64 percent of the patients operated on without ECC) and the patients who received the transfusions needed a smaller amount of allogeneic blood components, as well as fewer units administered through the transfusion. Conclusions: The strategies for saving blood were effective in order to reduce the homologous transfusions in the cardiac surgery perioperative.
Downloads
References
1. Muradás M, García R, Pérez Y, Sotolongo Y, Vigoa LP. Aspectos ético-legales y consideraciones anestésicas de la terapia transfusional en el paciente Testigo de Jehová [artículo de revisión]. Anales Cir Cardíaca Vasc. 2006;12(5):218-22.
2. Nuttall GA, Stehling LC, Beighley CM, Faust RJ. Current transfusión practices of members of the American Society of Anesthesiologists. Anesthesiology. 2003;99: 1433-43.
3. Douglas H. Transfusión. En: Davinson JK, Eckhardt WF, Perese DA, editores. Procedimientos del Massachussets General Hospital. 2dª ed. Massachussets; 1995. p. 477-90.
4. Cardemil HG. Cirugía, perioperatorio y sangre. Rev Chil Cir. 2003;55(3):216-24.
5. Salas J. Transfusión y cirugía cardiovascular. Cirugía Cardiovasc. 2003;10(1):7-16.
6. Jiménez J. CE. Recomendaciones médico-quirúrgicas para disminuir el uso y pérdida de derivados sanguíneos. Rev Colomb Cir [serie en Internet]. 2005 Jun [citado 10 Jul 2006];20(2):[aprox. 6 p]. Disponible en: http://www.encolombia.com/medicina/cirugia/Ciru20205-recomendaciones.htm
7. Iduni LE, Alvarado M, Méndez E. Autotransfusión y terapia de componentes sanguíneos autólogos en cirugía cardíaca: consideraciones generales y experiencia en el Hospital México. Rev Costarric Cardiol. 2003;5(1):9-18.
8. Beltrán HJ, Trujillo RME. Criterios actuales sobre el uso de sangre autóloga en cirugía. UNIV DIAG. 2002;2(1):37-51.
9. Baño RA, Domingo PF, Fernández P, Gómez GR. Guías de práctica clínica de la Sociedad Española de Cardiología en el postoperatorio de las cardiopatías congénitas. Rev Esp Cardiol. 2000;53(11):1496-1526.
10. Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost alter red blood transfusión in patients having cardiac surgery. Circulation. 2007;16:2544-52.
11. Murphy GJ, Connery C, Hicks GL, Blumberg N. Homologous blood transfusion as a risk factor for postoperative infection after CABG operations. J Thoracic Cardiovasc Surg. 1992;104:1092-7.
12. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogenic blood transfusion increases the risk of postoperative bacterial infection: A meta-analysis. J Trauma. 2003;54:908.
13. Triulzi DJ, Blumberg N, Heal JM. Association of transfusion with postoperative bacterial infection. Crit Rev Clin Lab Sci. 1990;28:95-102.
14. Taylor RW, Manganaro L, O’Brien J, Trottier SJ, Parkar N, Veremakis C. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med. 2002;30:2249-61.
15. Leal-Noval SR, Rincón-Ferrari MD, García-Curiel A, Herruzo-Avilés A, Camacho-Laraña P, Garnacho-Montero J, et al. Transfusion of blood components and postoperative infection in patients undergoig cardiac surgery. Chest. 2001;119(5): 1461-8.
16. Koch CG, Liang L, Duncan AI. Morbidity and mortality risk associated with red blood cell and blood component transfusion in isolated CABG. Crit Care Med. 2006;34:1608.
17. Dunne JR, Riddle MS, Danko J, Hyden R, Petersen K. Blood transfusion is associated with infection and increased resource utilization in combat casualties. Am Surgeon. 2006;72:619.
18. Mary AM, Blumberg N, Heal JM, Hicks GL. Increased risk of infection and mortality in women after cardiac surgery related to allogeneic blood transfusion. J of Women Health. 2007;16(10):1412-20.
19. González O, Hidalgo PA. Técnicas actuales para la cirugía cardíaca sin componentes sanguíneos. Rev Cubana Anest y Rean. 2007;6(1):45-62.
20. Reyes G, Nuche JM, Sarraj A, Cobiella J, Martín G, Celemín R, et al. Cirugía cardíaca sin sangre en testigos de Jehová: resultados frente a grupo de control. Rev Esp Cardiol. 2007;60(7):727-31.
21. Pérez F, Gredilla E, Vicente J, Fernández J, Barbero F. Negativa de los testigos de Jehová a las transfusiones: aspectos éticos, legales, religiosos y consideraciones anestésicas. Rev Esp Anestesiol Rean. 2006;53:31-41.
22. Bernal JM, Naranjo S, Trugeda M, Sarralde A, Diago C, Revuelta JM. Cirugía cardíaca en testigos de Jehová. Experiencia en Santander. Rev Esp Cardiol. 2006;59:507-9.
23. Zetina H, Martínez E, Calderón M, Venegas D, Rentaría MC, Méndez R. Cirugía cardíaca en testigos de Jehová. Experiencia y manejo en el IMSS. Rev Asoc Mexicana de Med Crítica y terapia Intensiva. 2001;15(5):151-5.
24. Cortés BA. Alternativas farmacológicas a las transfusiones de sangre y componentes. Colombia Médica. 1994;25:73-82.
25. Ladosis.com [sitio web en Internet]. Cali: Medicom S.A; ©2000-2009 [ actualizado 3 Sep 2005; citado 12 Jul 2006]. Disponible en: http://www.ladosis.com/clientes/valle_lili/carta/carta_new.php
26. Viteri OM. Uso de hemoderivados y técnicas de conservación de sangre. Rev Venez Anest. 2002;7(2):215-24.
27. Miller RD. Transfusion therapy. En: Miller RD. Anesthesia. 2da ed. New York: Churchill Livingstone; 2004. p. 1617-49.
28. Jacobs AK. Women, ischemic heart disease, revascularization, and the gender gap. J Am Coll Cardiol. 2006;47:63-74.
29. Rogers MA, Blumberg N, Saint SK, Kim C, Langa KM. Allogeneic blood transfusions explain increased mortality in women after coronary bypass graft surgery. Am Heart J. 2006;152:1028.
30. Cortina L. Terapia transfusional en cirugía con circulación extracorpórea. En: Cortina L. Guía de transfusionología IV. La Habana: ISCM; 2005. p. 6-9.
31. Bernabé SM, Calderón AM, Sánchez VL. Recuperación sanguínea intraoperatoria. Rev Asoc Mex Med Crít Ter Int. 2002;16(1):12-5.
32. Cochrane Plus [database on the Internet]. Centro Latinoamericano y del Caribe de Información en Ciencias de la Salud: BIREME. ©Bireme/OPS/OMS [cited 2009 Jun12]. Available from: http://cochrane.bvsalud.org/cochrane/main.php?lang=es&lib=BCP
33. Pontón CA, Díaz DB. Autotransfusión de sangre recuperada del drenaje mediastínico en cirugía cardíaca. Arch Med. 2005;44(1):51-7.
34. de la Parte PL. Valor del ácido épsilon aminocaproico en anestesia cardiovascular pediátrica. Rev Cub Cir. 2005;44(1):64-70.
35. León VA, Martínez GL, Orizondo PS. Uso del ácido épsilon aminocaproico en cirugía de tórax. Rev Cubana Cir. 2001;40(2):112-8.
36. Pérez PG, Martínez C. Tratamiento con desmopresina (DDAVP) previo a la analgesia epidural del parto a una paciente con enfermedad de VonWillebrand. Rev Esp Anest Rean. 2003;(50):526-9.
37. Hidalgo Menéndez PA, González Alfonso O, Méndez Martínez J, Moré Duarte A, Fuentes Herrera L, Rodríguez Hernández RO, et al. Cirugía cardíaca sin transfusiones alogénicas: Un año de experiencia en el Cardiocentro de Santa Clara. Rev Mex Patol Clin. 2009;56(2):105-12.
38. Cardemil HG, Rodríguez MF, Baeza GF, Reyes OD. Resultados del programa de atención médico-quirúrgica sin el uso de sangre ni hemoderivados del Hospital Clínico de la Universidad de Chile. Rev Chilena Cir. 2004;56(3):232-6.
39. Benneth E, Veldman TH, Doctor A, Telen M, Ortel T, Scott R. Evolution of adverse changes in stored RBCs. PNAS. 2007;104(43):17063-8.
Downloads
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
